From 2008 to 2023, there has been a significant decrease in cystic fibrosis mortality rates and a significant rise in sickle ...

The launch of BIRSA 101 marks a major breakthrough in CRISPR gene-editing technology, positioning India to deliver affordable ...

November marks National Family Caregivers Month, honoring the nearly one in four U.S. adultswho provide essential, often ...

Discover how living with sickle cell disease can become a journey of purpose. Learn to find meaning, resilience, and hope ...

Boz, read what the TLC legend had to say about promoting HIV prevention with “So We PrEP,” her bond with Chilli, and much ...

Shares in Agios Pharma lost nearly half their value in pre-market trading today after it posted mixed clinical results from a ...

Women with sickle cell disease have a significantly higher likelihood of developing preeclampsia than the general population, but a blood test could identify which patients have the greatest risk.A ...

Darlaine and Dwight Carson say they both knew they carried the sickle cell trait but never imagined their daughter would have ...

The world-class, low-cost gene editing solution named "BIRSA 101", in honour of Bhagwan Birsa Munda, remembered as a great ...

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) ranks among the most oversold biotech stocks to invest in. On November 20, Leerink ...

Pyrukynd, which Agios sells for a rare type of anemia, missed one of its main objectives in a study seen as crucial for its ...

Medunik USA, a specialty pharmaceutical company, and part of Duchesnay Pharmaceutical Group (DPG), is dedicated to providing ...